X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Panacea Biotech - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PANACEA BIOTECH UNICHEM LAB/
PANACEA BIOTECH
 
P/E (TTM) x 22.0 80.7 27.3% View Chart
P/BV x 2.3 1.8 129.3% View Chart
Dividend Yield % 0.8 0.0 -  

Financials

 UNICHEM LAB   PANACEA BIOTECH
EQUITY SHARE DATA
    UNICHEM LAB
Mar-16
PANACEA BIOTECH
Mar-14
UNICHEM LAB/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs334149 224.6%   
Low Rs17482 211.4%   
Sales per share (Unadj.) Rs146.984.1 174.6%  
Earnings per share (Unadj.) Rs11.9-18.3 -65.0%  
Cash flow per share (Unadj.) Rs16.2-6.7 -241.6%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs105.183.7 125.6%  
Shares outstanding (eoy) m90.8461.25 148.3%   
Bonus/Rights/Conversions ESOP--  
Price / Sales ratio x1.71.4 126.0%   
Avg P/E ratio x21.4-6.3 -338.5%  
P/CF ratio (eoy) x15.7-17.2 -91.0%  
Price / Book Value ratio x2.41.4 175.1%  
Dividend payout %16.80-   
Avg Mkt Cap Rs m23,0737,074 326.2%   
No. of employees `0005.72.8 206.3%   
Total wages/salary Rs m2,5581,449 176.5%   
Avg. sales/employee Rs Th2,352.51,874.1 125.5%   
Avg. wages/employee Rs Th450.9527.0 85.6%   
Avg. net profit/employee Rs Th190.4-407.7 -46.7%   
INCOME DATA
Net Sales Rs m13,3465,154 259.0%  
Other income Rs m192100 192.3%   
Total revenues Rs m13,5385,254 257.7%   
Gross profit Rs m1,639-766 -213.9%  
Depreciation Rs m390711 54.9%   
Interest Rs m291,503 1.9%   
Profit before tax Rs m1,412-2,881 -49.0%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-4-6 64.9%   
Extraordinary Inc (Exp) Rs m-351,771 -2.0%   
Tax Rs m29317 1,742.3%   
Profit after tax Rs m1,080-1,121 -96.4%  
Gross profit margin %12.3-14.9 -82.6%  
Effective tax rate %20.7-0.6 -3,554.0%   
Net profit margin %8.1-21.8 -37.2%  
BALANCE SHEET DATA
Current assets Rs m5,9793,810 156.9%   
Current liabilities Rs m2,4328,365 29.1%   
Net working cap to sales %26.6-88.4 -30.1%  
Current ratio x2.50.5 539.8%  
Inventory Days Days63156 40.5%  
Debtors Days Days6067 89.8%  
Net fixed assets Rs m6,40314,480 44.2%   
Share capital Rs m18261 296.4%   
"Free" reserves Rs m9,293903 1,029.0%   
Net worth Rs m9,5485,127 186.2%   
Long term debt Rs m2305,832 4.0%   
Total assets Rs m12,84319,433 66.1%  
Interest coverage x50.0-0.9 -5,458.9%   
Debt to equity ratio x01.1 2.1%  
Sales to assets ratio x1.00.3 391.8%   
Return on assets %8.62.0 439.7%  
Return on equity %11.3-21.9 -51.7%  
Return on capital %14.33.6 394.2%  
Exports to sales %29.224.5 119.2%   
Imports to sales %6.310.2 62.3%   
Exports (fob) Rs m3,9001,264 308.6%   
Imports (cif) Rs m847525 161.3%   
Fx inflow Rs m4,3561,539 283.0%   
Fx outflow Rs m1,162942 123.4%   
Net fx Rs m3,194597 534.8%   
CASH FLOW
From Operations Rs m1,119599 186.8%  
From Investments Rs m-853-438 194.9%  
From Financial Activity Rs m-334-303 110.4%  
Net Cashflow Rs m-68-141 48.3%  

Share Holding

Indian Promoters % 50.1 74.5 67.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.6 2,516.7%  
FIIs % 3.0 1.3 230.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 23.6 134.3%  
Shareholders   20,176 10,259 196.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUVEN LIFE  SHASUN PHARMA  PFIZER  FDC LTD.  SUN PHARMA  

Compare UNICHEM LAB With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Post Noon Sell-Off; Infosys Falls 5.4%(Closing)

Share markets in India witnessed a sharp fall in the final minutes of trade. At the closing bell, the BSE Sensex closed lower by 266 points. While, the NSE Nifty finished lower by 83 points.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

The Most Profitable Investment in the History of the World(Vivek Kaul's Diary)

Aug 8, 2017

'Yes, it looks like a bubble. And, yes, it's like buying a lottery ticket. But there's something happening that has never happened before. It's an evolutionary leap in money itself.'

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

Bitcoin Continues Stellar Rise(Chart Of The Day)

Aug 10, 2017

Bitcoin hits an all-time high, is there more upside left?

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Aug 21, 2017 03:37 PM

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - DISHMAN PHARMA COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS